Latest Ratios: P/E Ratio 19.1x · EV/EBITDA 13.4x · ROE 23.7%. (2002–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $143M | $142M | — | — | — | — | — | — | — | — | — |
| Enterprise Value | $140M | $139M | — | — | — | — | — | — | — | — | — |
| P/E Ratio → | 19.10 | 18.95 | — | — | — | — | — | — | — | — | — |
| P/S Ratio | 2.22 | 2.21 | — | — | — | — | — | — | — | — | — |
| P/B Ratio | 3.48 | 3.46 | — | — | — | — | — | — | — | — | — |
| P/FCF | 20.59 | 20.48 | — | — | — | — | — | — | — | — | — |
| P/OCF | 18.36 | 18.26 | — | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.17 | — | — | — | — | — | — | — | — | — |
| EV / EBITDA | 13.42 | 13.35 | — | — | — | — | — | — | — | — | — |
| EV / EBIT | 14.01 | 12.50 | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | 20.10 | — | — | — | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 45.9% | 45.9% | 42.7% | 99.4% | 41.0% | 52.0% | 30.7% | 35.1% | 28.9% | -4.9% | -9.7% |
| Operating Margin | 15.6% | 15.6% | 13.5% | 10.2% | 10.5% | 16.0% | -14.5% | 8.6% | 4.1% | -27.0% | -214.2% |
| Net Profit Margin | 11.7% | 11.7% | 11.1% | 7.5% | 7.6% | 16.6% | -4.2% | 7.9% | -12.4% | -17.8% | -207.1% |
| Metric | TTM | FY 2025 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 23.7% | 23.7% | 27.0% | 18.4% | 19.0% | 112.6% | -11.3% | — | — | — | — |
| ROA | 14.4% | 14.4% | 16.4% | 11.1% | 12.1% | 67.0% | -0.1% | 3.0% | -3.9% | -3.8% | -39.8% |
| ROIC | 27.1% | 27.1% | 32.6% | 31.1% | 48.2% | 136.7% | -0.3% | 3.7% | 1.8% | -7.5% | -47.1% |
| ROCE | 24.9% | 24.9% | 28.6% | 22.0% | 24.9% | 99.0% | -1.0% | 5.2% | 1.4% | -6.2% | -43.4% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.43 | 0.43 | 0.22 | 0.36 | 0.07 | 0.10 | 0.20 | — | — | — | — |
| Debt / EBITDA | 1.70 | 1.70 | 0.75 | 1.44 | 0.28 | 0.12 | — | 6.40 | 9.41 | 18.02 | — |
| Net Debt / Equity | — | -0.06 | -0.25 | -0.24 | -0.57 | -0.61 | -0.03 | — | — | — | — |
| Net Debt / EBITDA | -0.25 | -0.25 | -0.85 | -0.97 | -2.26 | -0.71 | — | 6.40 | 9.41 | 17.99 | — |
| Debt / FCF | — | -0.38 | -4.52 | -2.37 | -9.85 | -1.45 | — | — | — | — | — |
| Interest Coverage | 98.78 | 98.78 | 60.12 | 41.15 | 32.66 | 71.76 | -7.82 | -0.01 | 0.41 | 0.31 | -8.14 |
Net cash position: cash ($20M) exceeds total debt ($18M)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.69 | 2.69 | 2.35 | 2.04 | 2.47 | 2.18 | 1.57 | 0.15 | 0.78 | 0.96 | 1.60 |
| Quick Ratio | 2.60 | 2.60 | 2.35 | 1.99 | 2.40 | 2.13 | 1.54 | 0.15 | 0.78 | 0.96 | 1.60 |
| Cash Ratio | 1.47 | 1.47 | 0.99 | 1.09 | 1.37 | 1.26 | 0.37 | 0.00 | 0.01 | 0.03 | 0.02 |
| Asset Turnover | — | 0.93 | 1.31 | 1.30 | 1.49 | 3.22 | 1.53 | 0.38 | 0.29 | 0.24 | 0.21 |
| Inventory Turnover | 29.09 | 29.09 | — | 44.15 | 40.91 | 75.11 | 91.50 | — | — | — | — |
| Days Sales Outstanding | — | 86.80 | 103.82 | 75.17 | 73.85 | 30.00 | 94.50 | 1.98 | 75.44 | 77.34 | 64.01 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | 34.4% | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 5.2% | 5.3% | — | — | — | — | — | — | — | — | — |
| FCF Yield | 4.9% | 4.9% | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | — | — | — | — | — | — | — | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | — | — | — | — | — | — | — | — | — |
| Shares Outstanding | — | $13M | $12M | $28M | $28M | $27M | $15M | $69M | $72M | $71M | $69M |
California Regulatory Concentration Risk
Based on current market data, LGCY trades at a forward P/E of 16.93, which suggests investors are pricing in sustained expansion despite the inherent regulatory risks associated with the company's 100% geographic concentration in the California vocational education market compared to more diversified national peers.
The current P/S multiple of 2.25 indicates a premium valuation relative to the broader education sector, likely driven by the company's rapid 39% revenue growth. However, this valuation appears to assume that the current clinical placement bottleneck will continue to favor LGCY's specialized programs, a premise that warrants caution given the potential for regulatory shifts.
As reported in recent financial statements, LGCY's ROIC has fluctuated between 4.1% and 14.2% over the last ten quarters, reflecting the capital-intensive nature of maintaining specialized medical diagnostic equipment and the inherent difficulty in scaling high-touch clinical training programs within a single-state regulatory environment.
The volatility in ROIC suggests that the company's ability to compound capital is highly sensitive to the timing of campus-level investments and the subsequent utilization of those assets. Investors should monitor whether the recent trend toward 7.1% ROIC represents a sustainable baseline or merely a cyclical recovery from lower utilization periods.
According to quarterly filings, LGCY's asset turnover has remained low, hovering near 0.29, which highlights the significant investment in physical infrastructure required to support its vocational training model and the ongoing challenge of optimizing student throughput within the constraints of mandated clinical placement ratios.
The variability in DSO, which has ranged from 70 to over 360 days, suggests potential friction in the tuition collection process or reliance on institutional financing. This inconsistency in working capital management may indicate that the company's rapid revenue growth is not yet supported by a mature, predictable cash collection cycle.
The P/E ratio is frequently misapplied to LGCY because it fails to account for the significant non-cash expenses and stock-based compensation that mask the underlying cash-generating capacity of the business, leading to an incomplete picture of the firm's true economic profitability in the vocational sector.
Analysts should prioritize P/FCF or EV/EBITDA over P/E to better capture the impact of capital expenditures on medical equipment and the volatility of working capital. Relying on P/E alone obscures the reality that reported net income may be significantly higher than the actual cash available for reinvestment or debt service.
Includes 30+ ratios · 22 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying LGCY stock.
Legacy Education Inc.'s current P/E ratio is 19.1x. The historical average is 18.9x. This places it at the 100th percentile of its historical range.
Legacy Education Inc.'s current EV/EBITDA is 13.4x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 13.3x.
Legacy Education Inc.'s return on equity (ROE) is 23.7%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 16.5%.
Based on historical data, Legacy Education Inc. is trading at a P/E of 19.1x. This is at the 100th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Legacy Education Inc. has 45.9% gross margin and 15.6% operating margin. Operating margin between 10-20% is typical for established companies.
Legacy Education Inc.'s Debt/EBITDA ratio is 1.7x, indicating moderate leverage. A ratio below 2x is generally considered financially healthy.